Ito, R <br/><br/>
A novel in vivo model for predicting myelotoxicity of chemotherapeutic agents using IL-3/GM-CSF transgenic humanized mice.  [electronic resource] 

 -  Toxicology letters  Nov 2017 
 - 152-157 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-3169 
<br/><br/><label>Standard No.: </label>10.1016/j.toxlet.2017.09.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--toxicity<br/>Cell Differentiation--drug effects<br/>Cell Line, Tumor<br/>Colony-Forming Units Assay<br/>Dose-Response Relationship, Drug<br/>Granulocyte-Macrophage Colony-Stimulating Factor--genetics<br/>Granulocytes--drug effects<br/>Hematopoietic Stem Cells--drug effects<br/>Humans<br/>Inhibitory Concentration 50<br/>Interleukin-3--genetics<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, Transgenic<br/>Paclitaxel--toxicity<br/>Toxicity Tests